This randomized controlled trial (RCT) will examine a case management program for patients suffering from coronary heart disease with multimorbidity in Mannheim, Germany. The trail consists of 3 treatment arms: 1) intensified case management; 2) social interaction alone 3) standard care. The main objectives are to evaluate how case management and social interaction alone compared to standard medical care affect the primary and secondary outcomes: physical health, quality of life, loneliness, depression, self-efficacy, outcome expectancies, social support, health locus of control, lifestyle behavior, social network, vulnerability, intention, severity, health worries and cognitive functions.
This randomized controlled trial (RCT) will examine a case management program for 320 male and female patients suffering from coronary heart disease with multimorbidity in Mannheim, Germany. The main objectives are to evaluate how case management and social interaction alone compared to standard medical care affect the primary and secondary outcomes: physical health, quality of life, loneliness, depression, self-efficacy, outcome expectancies, social support, health locus of control, lifestyle behavior, social network, vulnerability, intention, severity, health worries and cognitive functions. Additionally, the secondary outcomes are studied as factors that mediate the effects of case management and social interaction alone compared to standard medical care on the primary outcomes. The trail consists of 3 treatment arms: 1) intensified case management; 2) social interaction alone 3) usual care. The intervention consists of a biweekly contact by trained case managers over the first 6-months and a monthly contact over the subsequent 6-months. Each contact involves an assessment of well-being, daily life, problems and offering emotional support and solutions or refer to the general practitioner if necessary (both intervention groups). For patients assigned to the "CM CHD" the contacts include medical control (like blood pressure or weight) and well-being as well as an additional core set of relevant outcome measures (e.g. need for treatment of fatigue). Patients assigned to the control group received usual care (no CM or contact). An additional fourth group is monitored. This group is consisting of patients who refused to take part in the study but gave consent to collect their practice data (not randomized). Each patient will be followed for 12 months. Extensive assessments and self-administered questionnaires take place at baseline, 6-month and 12-month for all patients in the three randomized groups.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
320
Patients, who are randomized to the intervention group, will receive case management from a trained and experienced physician assistant. The case manager will carry out following tasks: * Biweekly/monthly telephone consultations or home visits * Identification of health or personal problems of the patient * Monitoring of medical parameters * Coordination of contact with health care providers if necessary * Support to the patient related to health status and environmental changes * Promote disease-self management through coaching * Counseling, that is focused on emotional support and active listening
Identical as the CM CHD group, but with exclusion of medical control measures and the medical aspects.
Genossenschaft Gesundheitsprojekt Mannheim e.G.
Mannheim, Baden-Wurttemberg, Germany
Change in health outcomes
This includes biomarkers (blood pressure, BMI, weight, blood lipids), physical balance performance (semi tandem stand), care utilization and medication usage, clinical assessments and need for (medical) treatment (like dyspnea, fatigue, care, vomitus, thirst, lack of appetite, nausea, disorientation). Within the intervention group CM CHD weight and blood pressure is self-reported by patients biweekly within the first six months and monthly within the second six months.
Time frame: Measured at baseline, 6 and 12 months follow-up
Change in quality of life
We will measure this variable using the "EQ-5D" and two additional items.
Time frame: Measured at baseline, 6 and 12 months follow-up
Change in Loneliness
We will measure this variable using the "Hamburger Einsamkeits-Skala (HES)" a German version of the UCLA-Loneliness Scale.
Time frame: Measured at baseline, 6 and 12 months follow-up
Change in Depression
We will measure this variable using the "Patient Health Questionnaire - 9 item (PHQ-9) instrument".
Time frame: Measured at baseline, 6 and 12 months follow-up
Change in self-efficacy
We will measure this variable using the "SWE" questionnaire as well as items of self-efficacy regarding sports, quit smoking and healthier eating behavior.
Time frame: Measured at baseline, 6 and 12 months follow-up
Change in social support
We will measure this variable using the "Skala sozialer Unterstützung bei Krankheit (SSUK)". This instrument consists of two subscales, supportive behavior as well as stressful interactions.
Time frame: Measured at baseline, 6 and 12 months follow-up
Change in health locus of control
We will measure this variable using the "MHLC-C". This instrument consists of four subscales, internal, chance, doctors and other people.
Time frame: Measured at baseline, 6 and 12 months follow-up
Change in lifestyle behavior
This includes smoking, alcohol consumption, eating habits and physical activity.
Time frame: Measured at baseline, 6 and 12 months follow-up
Change in social network of family and friends
This includes the number of closer family members and friends and the amount of contact with them.
Time frame: Measured at baseline, 6 and 12 months follow-up
Change in outcome expectancies
This includes items regarding sports, quit smoking and healthier eating behavior.
Time frame: Measured at baseline, 6 and 12 months follow-up
Change in vulnerability
This includes the total vulnerability regarding specific diseases for one's own person as well as for a peer/other person. Thus the relative vulnerability can be determined.
Time frame: Measured at baseline, 6 and 12 months follow-up
Change in intention
This includes items of intentions for a healthier lifestyle like more physical activity, quit smoking and healthier eating behaviors.
Time frame: Measured at baseline, 6 and 12 months follow-up
Change in severity
This includes the estimated severity of different cardiovascular diseases in general as well as their severity for the own individual.
Time frame: Measured at baseline, 6 and 12 months follow-up
Change in health worries
This includes worries about the own health in general as well as regarding specific health problems like blood pressure, high cholesterol or the risk of a myocardial infarction.
Time frame: Measured at baseline, 6 and 12 months follow-up
Change in cognitive functions
This will be measured using the Mini-mental Status Exam and the Clock Drawing Test.
Time frame: Measured at baseline, 6 and 12 months follow-up
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.